Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review.

Title
Publication TypeJournal Article
Year of Publication2020
AuthorsKrishnaswami A, Beavers C, Dorsch MP, Dodson JA, Creber RMasterson, Kitsiou S, Goyal P, Maurer MS, Wenger NK, Croy DS, Alexander KP, Batsis JA, Turakhia MP, Forman DE, Bernacki GM, Kirkpatrick JN, Orr NM, Peterson ED, Rich MW, Freeman AM, Bhavnani SP
Corporate AuthorsInnovations, Cardiovascular Team and the Geriatric Cardiology Councils, American College of Cardiology
JournalJ Am Coll Cardiol
Volume76
Issue22
Pagination2650-2670
Date Published2020 12 01
ISSN1558-3597
KeywordsAged, Cardiovascular Diseases, Clinical Trials as Topic, COVID-19, Geriatrics, Humans, Internet Access, Long-Term Care, Pandemics, Population Dynamics, Smartphone, Subacute Care, Telemedicine, Wearable Electronic Devices
Abstract

The growing population of older adults (age ≥65 years) is expected to lead to higher rates of cardiovascular disease. The expansion of digital health (encompassing telehealth, telemedicine, mobile health, and remote patient monitoring), Internet access, and cellular technologies provides an opportunity to enhance patient care and improve health outcomes-opportunities that are particularly relevant during the current coronavirus disease-2019 pandemic. Insufficient dexterity, visual impairment, and cognitive dysfunction, found commonly in older adults should be taken into consideration in the development and utilization of existing technologies. If not implemented strategically and appropriately, these can lead to inequities propagating digital divides among older adults, across disease severities and socioeconomic distributions. A systematic approach, therefore, is needed to study and implement digital health strategies in older adults. This review will focus on current knowledge of the benefits, barriers, and use of digital health in older adults for cardiovascular disease management.

DOI10.1016/j.jacc.2020.09.606
Alternate JournalJ Am Coll Cardiol
PubMed ID33243384
Grant ListK23 AG052463 / AG / NIA NIH HHS / United States
R01 AG062520 / AG / NIA NIH HHS / United States
R00 NR016275 / NR / NINR NIH HHS / United States
R01 NR017635 / NR / NINR NIH HHS / United States
P30 AG022849 / AG / NIA NIH HHS / United States
R03 AG056444 / AG / NIA NIH HHS / United States
R01 HL139671 / HL / NHLBI NIH HHS / United States
R21 AG058348 / AG / NIA NIH HHS / United States
K24 AG036778 / AG / NIA NIH HHS / United States
K23 AG051681 / AG / NIA NIH HHS / United States
R01 AG067416 / AG / NIA NIH HHS / United States
R01 AG060499 / AG / NIA NIH HHS / United States
R01 AG058883 / AG / NIA NIH HHS / United States
P30 AG024827 / AG / NIA NIH HHS / United States
T32 HL125195 / HL / NHLBI NIH HHS / United States